Most recently both the EU and the US announced new legislation aiming to regulate the development and use of Artificial Intelligence: the EU AI Act and the President Biden Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence. Our panel of experts will discuss how these legal changes may affect research and development in drug discovery.
Agenda (please note these are in GMT times)
16:00 Introductions
Vladimir Makarov, Project Manager, Pistoia Alliance
16:05 How is AI used in your organization?
16.10 Review of current and proposed regulations
- Frederik van den Broek, Senior Director, Professional Services and Consulting, Elsevier
16:25 Panel Discussion with our speakers
- Frederik van den Broek, Senior Director, Professional Services and Consulting, Elsevier
- Koen Cobbaert, Senior Manager – Quality, Standards & Regulations, Philips
- Sophie Ollivier, Chief Data Officer R&D, Servier
- Gideon Rosenthal, Head of Research, Data Science Group
16:55 Closing Remarks and next steps
17:00 Close
Please click here to view a recording of this event and other past webinars.